Return to our Home Page


Tech Resources
Data Sheet
MSDS - English
Other Languages
Selected Citations
Certificate of Analysis
Store
-20°C-20°C
Ship
Shipped at Ambient TemperatureAmbient
Note: Store and Ship conditions may differ.
See Key
PubChem
SID: 26759689

Diabetes Resource

Inhibitor Email Sign Up

VEGF Signaling Pathway
  I-OMe-AG 538
Cat. No. 658417  
All Categories » Calbiochem » Inhibitors » Kinase and Phosphatase » Protein Tyrosine Kinase (PTK) » Receptor

a-Cyano-(3-methoxy,4-hydroxy,5-iodo)cinnamoyl-(3′,4′-dihydroxyphenyl)ketone
Tyrphostin I-OMe-AG 538

Dark yellow solid. PROTECT FROM LIGHT. PACKAGED UNDER INERT GAS. A cell-permeable analog of AG 538 (Cat. No. 658403) that acts as a competitive inhibitor of IGF-1 receptor kinase in intact cells in a dose-dependent manner. Exhibits enhanced cell-permeability and more resistance towards oxidation. Reported to inhibit IGF-1R kinase autophosphorylation (IC50 = 3.4 µM) as well as the phosphorylation of the PTK substrate poly(Glu,Tyr) (IC50 = 2 µM). Also inhibits the activation of the downstream targets PKB and ERK2 with the same potency as AG 538. Purity: ≥95% by HPLC.

Ref.: Blum, G., et al. 2000. Biochemistry 39, 15705.

Need additional information about this product? Email our Technical Service department at: technical@calbiochem.com

 Related information for this product is available:

EMD Chemicals Inc. list price is displayed (pricing with local distributors may vary). NOTE: In Stock status is based on item availability worldwide.

Size
In Stock
Select Country Above
For Pricing Information
5 mgYN/A

SolubilityMolecular FormulaMol. Wt.
DMSO C17H12INO5 437.2 


Related Literature:

Diabetes and Obesity Brochure

Protein Kinase and Related Tools Brochure

Inhibitor Sourcebook

Material Safety Data Sheets:
658417: I-OMe-AG 538 - English
Bulgarian
Danish
Dutch
Finnish
French
German
Greek
Hungarian
Italian
Korean
Norwegian
Polish
Portuguese
Spanish
Swedish

Related Categories:
All Categories » Calbiochem » Inhibitors » Kinase and Phosphatase » Protein Tyrosine Kinase (PTK) » Receptor

Selected Citations:
  1. Rita Nahta, et al. (2005) Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Research 65, 11118-11128.